Industry News

AdCare Health Systems, Inc.,, a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term healthcare, today announced that management expects to report financial results for the second quarter of 2016 on Monday, August 15, 2016 before the market opens. Management will conduct a conference call on Monday, August 15, 2016 at 10 a.m. ET to discuss the results."/>
AdCare Schedules Conference Call to Discuss Second Quarter Financial Results
Genocea Biosciences, Inc., a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that it will host a conference call and live audio webcast on Thursday, August 4, 2016 at 9:00 a.m. ET to discuss financial results for the second quarter of 2016. Genocea management will provide an update on the Company's recent progress and upcoming milestones.. Interested participants and investors may access the..."/>
Genocea to Host Second Quarter 2016 Financial Results Conference Call & Webcast on August 4, 2016
STRATA Skin Sciences, Inc., a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release second quarter financial results on Thursday, August 11, after the market close. STRATA Skin Sciences President and Chief Executive Officer, Michael Stewart, and Christina Allgeier, Chief Financial Officer, will host a conference call at 4:30 pm..."/>
STRATA Skin Sciences, Inc. to Report 2nd Quarter 2016 Financial Results on Thursday, August 11
Editas Medicine, Inc., a leading genome editing company, and Fondazione Telethon and Ospedale San Raffaele, which operate a joint research collaboration known as the San Raffaele Telethon Institute for Gene Therapy, have entered into a scientific collaboration to research and develop genome edited hematopoietic stem cell and T cell therapies. The scientific work at SR-TIGET in Milan, Italy will be led by Luigi Naldini, M.D., Ph.D., SR-TIGET Director,..."/>
Editas Medicine Announces Scientific Multi-Year Collaboration with Fondazione Telethon and Ospedale San Raffaele  
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of liver diseases, and SAMIL Pharm. Co., Ltd. today announced the execution of a license agreement for an exclusive, royalty-bearing license for the commercialization of Aramchol™ for the treatment of fatty liver indications including nonalcoholic steatohepatitis, or NASH, in the..."/>
Galmed Pharmaceuticals and SAMIL Pharm Sign a License Agreement for the Commercialization of Aramchol™ in Korea
DarioHealth Corp., a leader in digital health and mobile health solutions and the developer of the Dario Smart Diabetes Management Solution, today announced that it has begun offering the Dario Smart Diabetes Management Solution direct to the consumer in Australia, via its Australian sponsor IBD Consulting. The company is offering consumers the ability to purchase the Dario All in One meter directly online at the website:..."/>
DarioHealth is Now Direct-to-Consumer in Australia
Exact Sciences Corporation today announced the upsizing and pricing of its previously announced underwritten public offering of common stock. The Company is selling 8,500,000 shares of common stock through the underwriters at a public offering price of $15.50 per share. The offering was increased to 8,500,000 shares from the previously announced offering of 7,000,000 shares due to market demand."/>
Exact Sciences Announces Upsizing and Pricing of Public Offering of Common Stock
Corium International, Inc. today announced that it will report financial results for the third fiscal quarter ended June 30, 2016 on Thursday, August 4, 2016 after the close of the U.S. financial markets. Corium will host a conference call and live audio webcast at 5:00 p.m. Eastern time, 2:00 p.m. Pacific time to discuss its financial results and recently announced clinical and regulatory developments.. Conference Call and Webcast Details."/>
Corium to Report Third Quarter Fiscal Year 2016 Financial Results on Thursday, August 4, 2016
Meridian Bioscience, Inc. today:. reported fiscal 2016 third quarter and first nine months net revenues of $50.7 million and $149.1 million, respectively, increases of 5% and 1%, respectively, from the same periods of the prior fiscal year; reported third quarter operating income of $13.7 million, a decrease of 5% from the same period of the prior fiscal year; reported nine months operating income of $42.5 million, a decrease of 1% from the same period of the..."/>
Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
Five Star Quality Care, Inc. today announced that it will issue a press release containing its second quarter 2016 financial results before the Nasdaq opens on Thursday, August 4, 2016. Eastern Time that morning, President and Chief Executive Officer Bruce Mackey, Chief Financial Officer Rick Doyle and Chief Operating Officer Scott Herzig will host a conference call to discuss these results. The conference call telephone number is 329-4332. Participants..."/>
Five Star Quality Care, Inc. Second Quarter 2016 Conference Call Scheduled for Thursday, August 4th
HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced total revenue of $68.7 million for the quarter ended June 30, 2016, compared to $73.6 million for the same period in 2015 and $55.1 million for the first quarter of 2016. Total revenue decreased approximately 7% year-over-year, which is..."/>
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue
Unilife Corporation today announced new management and Board appointments, a strategic focus on wearable injectors, and an update to its internal investigation. John Ryan, who has served as Interim Chief Executive Officer since March 2016 and Senior Vice President, General Counsel and Secretary since 2014, has been named President and Chief Executive Officer and appointed to the Board of Directors. Michael E. Kamarck, Ph.D., former President of..."/>
Unilife Announces New Leadership Team and Targeted Growth Strategy
Raptor Pharmaceutical Corp. today announced that the company will release second quarter 2016 financial results on Thursday, August 4, 2016, after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. EDT that day to discuss the financial results and provide a corporate update.. Dial-in Number: 522-1023 International Dial-in Number: 815-6269 Conference ID: 46079703."/>
Raptor Pharmaceutical to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4, 2016, at 4:30 p.m. EDT
Caladrius Biosciences, Inc., a cell therapy company combining an industry-leading development and manufacturing services provider, PCT, with a select therapeutic development pipeline, announces today that its product candidate CLBS03 was granted Fast Track designation by the US Food and Drug Administration for the treatment of type 1 diabetes mellitus, making it the first known therapeutic candidate for treatment of T1D to receive the..."/>
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Zimmer Biomet Holdings, Inc. today reported financial results for the quarter ended June 30, 2016. The Company reported second quarter net sales of $1.93 billion, an increase of 65.6% and an increase of 4.5% on an adjusted pro forma, constant currency basis, compared to the second quarter of 2015. Diluted net loss per share for the quarter was$, compared to a net loss per share of$ for the prior year period, and adjusted diluted earnings per share for..."/>
Zimmer Biomet Reports Second Quarter 2016 Financial Results
Surmodics, Inc., a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2016 third quarter, ended June 30, 2016.. “Surmodics continued to advance all key strategic growth..."/>
Surmodics Reports Third Quarter Fiscal 2016 Results
Chartwell Retirement Residences announced today that it has entered into a definitive agreement to acquire the 121- suite Tiffin House Retirement Residence in Midland, Ontario. Built in 2014 and located at 105 Pillsbury Drive, Tiffin House is a premier residence in an attractive and affluent neighbourhood on the east side of Midland, within close proximity to the waterfront of Midland Bay. The residence provides a full continuum of care with 48..."/>
Chartwell Announces Acquisition of a Modern Retirement Residence in Midland, Ontario
Intercept Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today announced that it will report its second quarter 2016 financial results prior to the NASDAQ market open on Thursday, August 4, 2016. Intercept management will conduct a conference call and audio webcast on Thursday, August 4, 2016 at 8:30 a.m. Eastern Time to discuss..."/>
Intercept to Report Second Quarter 2016 Financial Results on August 4 and Present at Upcoming Conference
Teleflex Incorporated on Thursday announced the declaration by its board of directors of a quarterly cash dividend of USD0.34 per share of common stock. This dividend is payable on 15 September 2016 to shareholders of record at the close of business on 15 August 2016.. Teleflex is a provider of medical technologies designed to improve the health and quality of people's lives."/>
Teleflex’s board declares USD0.34 quarterly dividend
RXi Pharmaceuticals Corporation, a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced that it will report its financial results for the second quarter ended June 30, 2016, and provide a business update on Thursday, August 11, 2016 after the close of the U.S. financial markets. A live audio webcast will begin at 4:30 p.m. EDT. The webcast link is available..."/>
RXi Pharmaceuticals to Webcast Second Quarter 2016 Financial Results on Thursday, August 11, 2016
ProMIS Neurosciences, a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced results in two presentations on its recent therapeutic developments at the Alzheimer's Association International Conference on July 27th, 2016 in Toronto, Ontario, Canada. "Our results presented at the AAIC meeting indicate that multiple monoclonal antibodies directed against five novel AD targets..."/>
ProMIS Neurosciences Announces Results in Two Presentations at the 2016 Alzheimer's Association International Conference
PDL BioPharma, Inc. today announced that the Company will release its second quarter 2016 financial results for the period ended June 30, 2016, on Thursday, August 4, 2016, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results. A slide presentation relating to the call will be available via the webcast link on the PDL website."/>
PDL BioPharma to Announce Second Quarter 2016 Financial Results on August 4, 2016

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials894 Articles
Information Technology883 Articles
Consumer Discretionary735 Articles
Health Care567 Articles
Industrials561 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.